Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) Gross Profit: 2016-2024

Historic Gross Profit for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $377.3 million.

  • Collegium Pharmaceutical's Gross Profit rose 33.45% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.2 million, marking a year-over-year increase of 15.92%. This contributed to the annual value of $377.3 million for FY2024, which is 15.69% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Gross Profit of $377.3 million as of FY2024, which was up 15.69% from $326.2 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Gross Profit high stood at $377.3 million for FY2024, and its period low was $150.6 million during FY2021.
  • In the last 3 years, Collegium Pharmaceutical's Gross Profit had a median value of $326.2 million in 2023 and averaged $304.3 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Gross Profit spiked by 74.53% in 2020 and then dropped by 16.25% in 2021.
  • Collegium Pharmaceutical's Gross Profit (Yearly) stood at $179.8 million in 2020, then fell by 16.25% to $150.6 million in 2021, then surged by 39.09% to $209.5 million in 2022, then skyrocketed by 55.70% to $326.2 million in 2023, then climbed by 15.69% to $377.3 million in 2024.